Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -1836.42%, near the high end of its 5-year range (-235203.24%–20988.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 89.53%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
89.53%
NET PROFIT MARGIN AVG 3Y
-4248.43%
NET PROFIT MARGIN AVG 5Y
-1836.42%
NET PROFIT MARGIN AVG 10Y
-1120.59%
NET PROFIT MARGIN AVG 15Y
-300.43%
NET PROFIT MARGIN AVG 20Y
-3132.66%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ABVC BioPharma, Inc.
Market Cap
$25.48M
Net Profit Margin
0.00%
TTM Avg
89.53%
3Y Avg
-4248.43%
5Y Avg
-1836.42%
Market Cap
$24.65M
Net Profit Margin
3967.77%
TTM Avg
1344.00%
3Y Avg
468.01%
5Y Avg
273.57%
Market Cap
$24.44M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$27.31M
Net Profit Margin
-12789.65%
TTM Avg
-8817.21%
3Y Avg
-4408.60%
5Y Avg
-2939.07%
Market Cap
$28.43M
Net Profit Margin
-32003.68%
TTM Avg
-33126.65%
3Y Avg
-20241.08%
5Y Avg
-13519.92%
Market Cap
$21.90M
Net Profit Margin
-24.76%
TTM Avg
-22.59%
3Y Avg
-21.34%
5Y Avg
-47.79%
Market Cap
$20.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$30.65M
Net Profit Margin
-9408.76%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$30.92M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $25.48M | 0.00% | 89.53% | -4248.43% | -1836.42% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | 3967.77% | 1344.00% | 468.01% | 273.57% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -12789.65% | -8817.21% | -4408.60% | -2939.07% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -32003.68% | -33126.65% | -20241.08% | -13519.92% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -24.76% | -22.59% | -21.34% | -47.79% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -9408.76% | 0.00% | 0.00% | 0.00% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -121.04% | -43.71% | -4.52% | 10.54% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 447.63% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 11663.48% |
| 2024-09-30 | -101.41% |
| 2024-06-30 | -804.44% |
| 2024-03-31 | -235203.24% |
| 2023-12-31 | -143692.10% |
| 2023-09-30 | -20885.90% |
| 2023-06-30 | -37052.07% |
| 2023-03-31 | -1421.74% |
| 2022-12-31 | -825.80% |
| 2022-09-30 | -8764.97% |
| 2022-06-30 | -594.19% |
| 2022-03-31 | -23364.93% |
| 2021-12-31 | 20988.69% |
| 2021-09-30 | -1824.75% |
| 2021-06-30 | -6270.68% |
| 2021-03-31 | -428.84% |
| 2020-12-31 | -7795.54% |
| 2020-09-30 | -1597.58% |
| 2020-06-30 | -816.42% |
| 2020-03-31 | -1583.45% |
| 2019-12-31 | -1078.08% |
| 2019-09-30 | -614.39% |
| 2019-06-30 | -290.73% |
| 2019-03-31 | -373.00% |
| 2018-12-31 | -126544.06% |
| 2018-09-30 | -76413.52% |
| 2018-06-30 | -19577.89% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -2806.36% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 49.51% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | -13702.50% |
| 2012-12-31 | -2189.05% |
| 2012-09-30 | 1414.92% |
| 2012-06-30 | 1918.66% |
| 2012-03-31 | -9354.43% |
| 2011-12-15 | -13518.79% |
| 2011-08-03 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 67046.39% |
| 2010-12-31 | -17163.52% |
| 2010-09-30 | -32897.03% |
| 2010-05-21 | -7387.77% |
| 2010-02-08 | -8815.51% |
| 2009-12-31 | -15318.23% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | -8105.96% |
| 2008-12-31 | 2220.97% |
| 2008-09-30 | -585524.04% |
| 2008-06-30 | -56230.40% |
| 2008-03-31 | -17385.04% |
| 2007-12-31 | -14055.87% |
| 2007-09-30 | -10975.00% |
| 2007-06-30 | -6857.97% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | -13715.84% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | -189.73% |
| 2004-12-31 | -339.42% |
| 2004-09-30 | 38.21% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | -585.24% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | -200.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | -100.00% |
